Literature DB >> 31989587

Incorporation of thiotepa in a reduced intensity conditioning regimen may improve engraftment after transplant for HLH.

Swati Naik1,2,3, Olive Eckstein2,3, Ghadir Sasa1,2,3, Helen E Heslop1,2,3,4, Robert A Krance1,2,3, Carl Allen1,2,3, Caridad Martinez1,2,3.   

Abstract

Entities:  

Keywords:  hemophagocytic lymphohistiocytosis; reduced intensity conditioning; transplantation

Mesh：

Substances：

Year:  2020        PMID： 31989587     DOI： 10.1111/bjh.16370

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders.

Authors:  Rebecca A Marsh; Kyle Hebert; Soyoung Kim; Christopher C Dvorak; Victor M Aquino; K Scott Baker; Deepak Chellapandian; Blachy Dávila Saldaña; Christine N Duncan; Michael J Eckrich; George E Georges; Timothy S Olson; Michael A Pulsipher; Shalini Shenoy; Elizabeth Stenger; Mark Vander Lugt; Lolie C Yu; Andrew R Gennery; Mary Eapen
Journal:  J Allergy Clin Immunol       Date:  2021-08-08       Impact factor: 10.793

2.  Treosulfan-based conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases.

Authors:  Jin Kyung Suh; Ho Joon Im; Sung Han Kang; Hyery Kim; Eun Seok Choi; Kyung-Nam Koh
Journal:  Bone Marrow Transplant       Date:  2022-02-07       Impact factor: 5.483

Review 3.  Histiocytic disorders.

Authors:  Kenneth L McClain; Camille Bigenwald; Matthew Collin; Julien Haroche; Rebecca A Marsh; Miriam Merad; Jennifer Picarsic; Karina B Ribeiro; Carl E Allen
Journal:  Nat Rev Dis Primers       Date:  2021-10-07       Impact factor: 65.038

4.  Favorable outcomes with durable chimerism after hematopoietic cell transplantation using busulfan and fludarabine-based reduced-intensity conditioning for pediatric patients with hemophagocytic lymphohistiocytosis.

Authors:  Jin Kyung Suh; Young Kwon Koh; Sung Han Kang; Hyery Kim; Eun Seok Choi; Kyung-Nam Koh; Ho Joon Im
Journal:  Blood Res       Date:  2022-06-10

Review 5.  EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity.

Authors:  A C Lankester; M H Albert; C Booth; A R Gennery; T Güngör; M Hönig; E C Morris; D Moshous; B Neven; A Schulz; M Slatter; P Veys
Journal:  Bone Marrow Transplant       Date:  2021-07-05       Impact factor: 5.483

Review 6.  Therapeutic Drug Monitoring of Conditioning Agents in Pediatric Allogeneic Stem Cell Transplantation; Where do We Stand?

Authors:  M Y Eileen C van der Stoep; Lisa V E Oostenbrink; Robbert G M Bredius; Dirk Jan A R Moes; Henk-Jan Guchelaar; Juliette Zwaveling; Arjan C Lankester
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.